Al-Attar, Nawwar http://orcid.org/0000-0002-0443-3319
Gaer, Jullien http://orcid.org/0000-0002-6618-3730
Giordano, Vincenzo
Harris, Emma http://orcid.org/0000-0003-0761-4796
Kirk, Alan http://orcid.org/0000-0001-7317-523X
Loubani, Mahmoud http://orcid.org/0000-0003-1826-6686
Meybohm, Patrick http://orcid.org/0000-0002-2666-8696
Sayeed, Rana http://orcid.org/0000-0002-2887-1874
Stock, Ulrich http://orcid.org/0000-0002-2497-258X
Travers, Jennifer http://orcid.org/0000-0003-0497-6919
Whiteman, Becky http://orcid.org/0000-0001-8857-7362
Article History
Received: 29 April 2022
Accepted: 29 March 2023
First Online: 1 April 2023
Declarations
:
: Not applicable.
: Nawwar Al-Attar and/or the Department received has received healthcare professional and organisation (HCP) compliant honoraria. Patrick Meybohm and/or the Department received research grants from the German Research Foundation (ME 3559/1-1, ME 3559/3-1), BMBF (01KG1815), BMG (ZMVI1-2520DAT10E), International Anesthesia Research Society, German Society of Anaesthesiology and Intensive Care Medicine, European Society of Anaesthesiology, grants by B. Braun Melsungen, CSL Behring, Fresenius Kabi and Vifor Pharma for the implementation of Frankfurt’s Patient Blood Management Program; by Pfizer and Dr. F. Köhler Chemie GmbH for investigator-initiated trial; honoraria for scientific lectures from Abbott GmbH &Co KG, Aesculap Academy, B.Braun Melsungen, Biotest AG, Vifor Pharma, Ferring, CSL Behring, German Red Cross/Institute of Transfusion Medicine, HCCM Consulting GmbH, Heinen&Löwenstein, Hemosonics, Pharmacosmos, Siemens Healthcare; prices from Aktionsbündnis Patientensicherheit (APS), European Society of Anaesthesiology (ESA), Lohfert-Stiftung AG, Masimo – Patient Safety Foundation, MSD-Gesundheitspreis. Becky Whiteman is an employee of Baxter Healthcare Limited, Wallingford Road, Compton, Berkshire, RG20 7QW, United Kingdom. All other authors declare that they have no competing interests.